Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
daniele.pastori@uniroma1.it
Daniele Pastori
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
daniele.pastori@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Poor adherence to mediterranean diet and serum lipopolysaccharide are associated with oxidative stress in patients with non-alcoholic fatty liver disease
NUTRIENTS
2020
Cancer-specific ischemic complications in elderly Patients with atrial fibrillation. data from the prospective ATHERO-AF study
INTERNATIONAL JOURNAL OF CANCER
2020
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes. insights from the multicenter START-ANTIPLATELET registry
INTERNAL AND EMERGENCY MEDICINE
2020
Antiphospholipid antibodies and autoimmune haemolytic anaemia. a systematic review and meta-analysis
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2020
Hypoalbuminemia, coagulopathy and vascular disease in covid-19
CIRCULATION RESEARCH
2020
SARS-CoV-2 and myocardial injury. a role for Nox2
INTERNAL AND EMERGENCY MEDICINE
2020
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta-Analysis
HEPATOLOGY COMMUNICATIONS
2020
Features of severe COVID-19. a systematic review and meta-analysis
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
2020
Effect of combination therapy of hydroxychloroquine and azithromycin on mortality in patients with COVID-19
CLINICAL AND TRANSLATIONAL SCIENCE
2020
Clinical and pharmacological characteristics of elderly patients admitted for bleeding. iimpact on in-hospital mortality
ANNALS OF MEDICINE
2020
Effects of atrial fibrillation and chronic kidney disease on major adverse cardiovascular events
THE AMERICAN JOURNAL OF CARDIOLOGY
2020
Antiphospholipid antibodies in end-stage renal disease. a systematic review and meta-analysis
HEMODIALYSIS INTERNATIONAL
2020
Increased liver localization of lipopolysaccharides in human and experimental NAFLD
HEPATOLOGY
2020
New insights into the pathogenesis of non-alcoholic fatty liver disease: gut-derived lipopolysaccharides and oxidative stress
NUTRIENTS
2020
Family history of atrial fibrillation and risk of cardiovascular events. a multicenter prospective cohort study
CIRCULATION. ARRHYTHMIA AND ELECTROPHYSIOLOGY
2020
T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort
INTERNATIONAL JOURNAL OF CARDIOLOGY
2020
The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF study
EUROPEAN JOURNAL OF INTERNAL MEDICINE
2020
Hdl-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically-but not genetically driven non-alcoholic fatty liver disease (Nafld)
BIOMEDICINES
2020
Treatment Decision-Making of Secondary Prevention After Venous Thromboembolism: Data From the Real-Life START2-POST-VTE Register
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
2020
Anticoagulation in patients with advanced liver disease: an open issue
INTERNAL AND EMERGENCY MEDICINE
2020
« prima
< precedente
…
2
3
4
5
6
7
8
9
10
11
12
13
seguente ›
ultima »
ERC
LS4
LS4_10
LS7
LS7_10
Keywords
cardiovascular disease
anticoagulation
Novel oral anticoagulants
atrial fibrillation
atherosclerosis
NAFLD
NASH
antiphospholipid antibody syndrome
ischemic heart disease
cardiovascular risk
Thrombosis
Atherothrombosis
Progetti di Ricerca
Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma